Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets - License Agreements (Details)

v3.20.2
Intangible Assets - License Agreements (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sales and Marketing Expense        
Intangible assets        
Royalty fees included in sales and marketing expense $ 701,000 $ 577,000 $ 1,635,000 $ 1,573,000
License Agreements        
Intangible assets        
Notice period for termination of license agreements     60 days  
Minimum royalty of agreements     $ 12,500  
Milestone fee upon receiving a Phase II Small Business Innovation Research     15,000  
Milestone fee upon FDA approval     125,000  
Milestone fee upon first commercial use of certain licensed technology     25,000  
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products     $ 10,000  
License Agreements | Minimum        
Intangible assets        
Royalty fees range under the license agreements     1.00%  
License Agreements | Maximum        
Intangible assets        
Royalty fees range under the license agreements     3.00%  
Royalty stack cap for royalties paid to more than one licensor for sales of the same product     3.75%